ImpediMed Limited is listed on the Australian Stock Exchange (ASX).
Trading in its securities is under the ticker code on ASX of “IPD” for ordinary shares, and there are also listed options trading under the ticker “IPDO”.
Shares may be bought on market through any Australian stock broker. Shares can also be bought through on-market trades, via a number of international broking houses. Any potential investors needing information how to trade in the shares through an international broking house should contact Morten Vigeland, ImpediMed’s Chief Financial Officer, on +1-760-585-2100+1-760-585-2100, or send an email to InvestorRelations@impedimed.com.
The company maintains an active program of communication with investors and the market generally. Investors interested in a presentation should contact the Chief Executive Officer – Rick Carreon on +61-7-3860-3700+61-7-3860-3700, or the Chief Financial Officer – Morten Vigeland on +1-760-585-2100+1-760-585-2100, or send an email to InvestorRelations@impedimed.com